SCHEMBL29944865

SCHEMBL29944865

CCOc1ccc(N(C)S(=O)(=O)c2ccsc2C(=O)Nc2cccc(C(=O)N(C)C)c2)cc1

nearest known ligand 0.73

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SREBF1 P36956 10/20 0.73
NR1H3 Q13133 7/20 0.73
NR1H2 P55055 7/20 0.73
KMT2A Q03164 4/20 0.48
NPC1 O15118 3/20 0.48
MEN1 O00255 3/20 0.48
RECQL P46063 1/20 0.46
SMN1; SMN2 Q16637 4/20 0.45
RAB9A P51151 2/20 0.45
MITF O75030 1/20 0.45
PAX8 Q06710 1/20 0.45
ALDH1A1 P00352 2/20 0.45
MAPK1 P28482 1/20 0.44
MAPT P10636 1/20 0.44
KDM4E B2RXH2 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27245377 0.93 SREBF1 (0.71) SREBF1NR1H3NR1H2KMT2ANPC1
SCHEMBL29944849 0.93 SREBF1 (0.71) SREBF1NR1H3NR1H2KMT2ANPC1
SCHEMBL27030433 0.93 SREBF1 (0.75) SREBF1NR1H3NR1H2KMT2ANPC1
SCHEMBL29944875 0.93 SREBF1 (0.75) SREBF1NR1H3NR1H2KMT2ANPC1
SCHEMBL27030385 0.92 SREBF1 (0.74) SREBF1NR1H3NR1H2KMT2ANPC1
SCHEMBL29944885 0.92 SREBF1 (0.74) SREBF1NR1H3NR1H2KMT2ANPC1
SCHEMBL27030557 0.91 SREBF1 (0.73) SREBF1NR1H3NR1H2KMT2ANPC1
SCHEMBL27030466 0.91 SREBF1 (0.73) SREBF1NR1H3NR1H2KMT2ANPC1
SCHEMBL27245358 0.91 SREBF1 (0.85) SREBF1NR1H3NR1H2KMT2ANPC1
SCHEMBL29944846 0.90 SREBF1 (0.72) SREBF1NR1H3NR1H2KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4308554-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING TYPE 2 DIABETES AND DEMENTIA The Board of Trustees of the University of Illinois (US) 2024-01-24 EP disclosed
WO-2022197658-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING TYPE 2 DIABETES AND DEMENTIA THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2022-09-22 WO disclosed